Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 8/20 | 0.71 |
| ▸ | BLM | P54132 | 4/20 | 0.69 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.68 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.67 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.67 |
| ▸ | CHRM3 | P20309 | 5/20 | 0.67 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.67 |
| ▸ | MEN1 | O00255 | 3/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.67 |
| ▸ | TSHR | P16473 | 2/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Xenytropium SCHEMBL29361010 | 1.00 | CHRM2 (0.71) | CHRM2BLMPABPC1CYP2C19CHRM5 | |
| Xenytropium SCHEMBL29371652 | 0.99 | BLM (0.71) | CHRM2BLMPABPC1CYP2C19CHRM5 | |
| Xenytropium SCHEMBL24707 | 0.99 | BLM (0.71) | CHRM2BLMPABPC1CYP2C19CHRM5 | |
| Bromide SCHEMBL29840597 | 0.93 | BLM (0.77) | CHRM2BLMPABPC1CYP2C19CHRM5 | |
| Butropium SCHEMBL29388793 | 0.86 | CHRM2 (0.63) | CHRM2BLMPABPC1CYP2C19CHRM5 | |
| Fentonium SCHEMBL251444 | 0.86 | CHRM2 (0.68) | CHRM2BLMPABPC1CYP2C19CHRM5 | |
| Butropium SCHEMBL11561521 | 0.86 | BLM (0.64) | CHRM2BLMPABPC1CYP2C19CHRM5 | |
| Butropium SCHEMBL1650524 | 0.86 | BLM (0.64) | CHRM2BLMPABPC1CYP2C19CHRM5 | |
| Butropium SCHEMBL26023 | 0.86 | BLM (0.64) | CHRM2BLMPABPC1CYP2C19CHRM5 | |
| Butropium SCHEMBL30185784 | 0.86 | BLM (0.64) | CHRM2BLMPABPC1CYP2C19CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260097102-A1 | Treatment Of Respiratory Disorders With Arachidonate 15-Lipoxygenase (ALOX15) Inhibitors | REGENERON PHARMA (US) | 2026-04-09 | — | — | US | disclosed |
| US-12472241-B2 | Treatment of respiratory disorders with arachidonate 15-lipoxygenase (ALOX15) inhibitors | REGENERON PHARMACEUTICALS, INC. (US) | 2025-11-18 | — | — | US | disclosed |
| US-20230172904-A1 | COMBINATION OF AN ANTIALLERGIC AGENT WITH MUSCARINIC ANTAGONIST AND/OR DOPAMINERGIC AGONIST FOR USE IN PREVENTING/STOPPING OF AXIAL MYOPIA IN HUMAN | DAMBROSIO ENZO MARIA (IT) | 2023-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260097102-A1 | Treatment Of Respiratory Disorders With Arachidonate 15-Lipoxygenase (ALOX15) Inhibitors | ALOX15, ALOX15B, ALOX5 | CHRM2 4475/4885BLM 924/4885PABPC1 270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.